BNP/CALL/NOVONESIS B/420/0.1/20.09.24 Stock

Warrant

DE000PC5CKY2

Real-time Boerse Frankfurt Warrants 10:21:04 2024-07-16 EDT
0.33 EUR -13.16% Intraday chart for BNP/CALL/NOVONESIS B/420/0.1/20.09.24
Current month+2.70%
1 month+40.74%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-16 0.33 -13.16%
24-07-15 0.38 -2.56%
24-07-12 0.39 +5.41%
24-07-11 0.37 +2.78%
24-07-10 0.36 -7.69%

Real-time Boerse Frankfurt Warrants

Last update July 16, 2024 at 10:21 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying NOVONESIS A/S
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC5CKY
ISINDE000PC5CKY2
Date issued 2024-02-20
Strike 420 kr
Maturity 2024-09-20 (66 Days)
Parity 10 : 1
Emission price 0.13
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.54
Lowest since issue 0.2
Spread 0.01
Spread %2.86%

Company Profile

Novonesis A/S (formerly Novozymes A/S) is the world's leading producer of enzymes and microorganisms for industrial companies. Net sales break down by market as follows: - industry of cleaning and household maintenance products (28.5%); - bioenergy (24.8%); - food industry and human health (22.1%); - technical and cereal industries (12.8%): microorganisms used in the field of wastewater treatment, technical enzymes intended for the textile, leather, pulp and paper industries; - agriculture and animal feed industry (11.8%): enzymes used to improve the productivity and digestion of certain foods. Net sales are geographically distributed as follows: Denmark (1.3%), Europe/Middle East/Africa (33.5%), North America (33.9%), Asia/Pacific (18.5%) and Latin America (12.8%).
Sector
-
More about the company

Ratings for Novonesis A/S

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Novonesis A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
429.3 DKK
Average target price
455.6 DKK
Spread / Average Target
+6.13%
Consensus